Cd133-functionalized gold nanoparticles as a carrier platform for telaglenastat (cb-839) against tumor stem cells

HIGHLIGHTS

• who: Elham Poonaki and collaborators from the Department of Neurology, Faculty of Medicine, Heinrich-Heine-University, Du00fcsseldorf, Germany have published the research: CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells, in the Journal: (JOURNAL)
• what: In the current study, the authors attempted to ameliorate the methods such as employing a higher molecular weight of PEG along with some modifications in the chemical reaction process, leading to successfully loading of CB-839 at approximately 30% around Au-PEG-CD133 particles. The authors acknowledge the study has certain limitations . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.